Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia
NCT01380587 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2013-08-27
Summary
The purpose of the study is to determine the utility of XCL1 in the prognosis of acute lymphoblastic leukemia.
Conditions
Sponsors & Collaborators
-
Hospital Universitario Dr. Jose E. Gonzalez
lead OTHER
Principal Investigators
-
Cesar H Gutierrez Aguirre, MD · Hospital Universitario Dr. Jose E. Gonzalez UANL
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2012-09-30
- Completion
- 2012-09-30
Countries
- Mexico
Study Locations
More Related Trials
-
RFC and MTHFR SNPs & hENT1- dCK Expression as Prognostic Factors in ALL & hENT1- dCK Expression as Prognostic Factors in AML
NCT01307241 ·Status: UNKNOWN
-
Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia
NCT01284010 ·Status: COMPLETED
-
Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia
NCT01540578 ·Status: COMPLETED
-
C-X-C Chemokine Receptor 4 in Chronic Lymphocytic Leukemia
NCT03150849 ·Status: UNKNOWN
-
Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)
NCT00593944 ·Status: COMPLETED ·Phase: PHASE1
-
Genotyping Analysis of Acute Lymphoblastic Leukemia
NCT00961285 ·Status: UNKNOWN
-
An Observational Study on The Health Related Quality of Life in Patients With Chronic Lymphocytic Leukaemia
NCT01395615 ·Status: COMPLETED
-
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT01142427 ·Status: COMPLETED
-
LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION
NCT07313982 ·Status: RECRUITING
-
Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis
NCT00481858 ·Status: COMPLETED
-
Evaluation of the Ambulatory Medical Assistance Nurse Program in Chronic Lymphocytic Leukemia
NCT05350826 ·Status: UNKNOWN ·Phase: NA
-
Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia
NCT05893836 ·Status: COMPLETED
-
Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
NCT00759798 ·Status: COMPLETED ·Phase: PHASE2
-
Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia: a Prospective Multicentric Study.
NCT04311060 ·Status: NOT_YET_RECRUITING
-
Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
NCT00751296 ·Status: TERMINATED ·Phase: PHASE2
-
Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL
NCT04215809 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT01185886 ·Status: UNKNOWN
-
Quality of Life Study for Adult Patients With Acute Lymphoblastic Leukemia
NCT01148927 ·Status: COMPLETED
-
Results From a Mexican Acute Promyelocytic Leukemia.
NCT04562818 ·Status: COMPLETED
-
Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia
NCT01505699 ·Status: COMPLETED
-
Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00482352 ·Status: COMPLETED
-
Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma
NCT07030400 ·Status: RECRUITING
-
Overweight and Obesity as Prognostic Factors for Survival in Children With Acute Lymphoblastic Leukemia
NCT04271215 ·Status: UNKNOWN
-
A Study to Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in Spain
NCT06125795 ·Status: ACTIVE_NOT_RECRUITING
-
Genomic Changes in Childhood Acute Lymphoblastic Leukemia
NCT01089907 ·Status: UNKNOWN